期刊文献+

高血压家族史者健康子女血浆E选择素、血管紧张素Ⅱ及降钙素基因相关肽水平变化 被引量:2

PLASMA LEVELS OF E-SELECTIN,ANGⅡ AND CGRP OF HEALTHY OFFSPRINGS WITH A FAMILY HISTORY OF ESSENTIAL HYPERTENSION
下载PDF
导出
摘要 目的检测有高血压家族史的健康子女血浆E选择素(E-selectin)、血管紧张素Ⅱ(AngⅡ)及降钙素基因相关肽(CGRP)水平,探讨其在高血压发病机制中的作用。方法随机选择60例有高血压家族史的健康子女为研究组,其中父亲或母亲一方患高血压的30例为单亲组,双亲均患高血压的30例为双亲组,以双亲均无高血压的健康子女30例为对照组。用酶联免疫吸附法测定血浆E-selectin含量,用放射免疫法测定血浆AngⅡ、CGRP含量。结果研究组血浆E-selectin、AngⅡ、CGRP含量均高于对照组,差异有统计学意义(F=14.43~16.63,q=3.52~8.15,P〈0.05);双亲组血浆E-selectin、AngⅡ、CGRP含量均高于单亲组,差异有统计学意义(q=3.12~3.98,P〈0.05)。研究组血浆CGRP与AngⅡ水平呈正相关(r=0.682,P〈0.01)。结论有高血压家族史的健康子女受遗传因素的影响,血浆E-selectin、AngⅡ、CGRP水平升高,这可能是高血压的始动因素。发现血浆E-selectin、AngⅡ、CGRP水平升高的有高血压家族史的健康子女,可能是高血压的高危对象,应积极采取一级预防措施防止高血压的发生。 Objective To study the plasma levels of E-selectin,angiotensin Ⅱ(Ang Ⅱ) and calcitonin gene-related peptide(CGRP) of healthy offsprings with a family history of essential hypertension(EH),and explore their effects on pathogenesis of EH. Methods Sixty healthy offsprings with a family history of EH were randomly divided into two groups: 30 offsprings with one of the parents suffering from EH as group A;30 with both parents suffering from EH as group B.Another 30 healthy offsprings whose parents did not suffer from EH were assigned as control group.The plasma level of E-selectin was determined by enzyme linked immunosorbentassay(ELISA) method and the levels of Ang Ⅱ and CGRP were determined by radioimmunoassay.Results The plasma levels of E-selectin,Ang Ⅱ and CGRP were significantly higher in groups A and B than that in the control(F=14.43-16.63,q=3.52-8.15,P0.05).Plasma levels of E-selectin,AngⅡ and CGRP were higher in group B than that in group A(q=3.12-3.98,P0.05).Levels of CGRP were positively correlated with that of Ang Ⅱ in groups A and B(r=0.682,P0.01). Conclusion Due to heredity,the plasma levels of E-selectin,Ang Ⅱ and CGRP increase in the healthy offsprings with a family history of EH,which might be regarded a initiating agent for EH.Healthy children with a family history of EH and with high plasma levels of E-selectin,Ang Ⅱ and CGRP are high-risk objects of EH,an active prevention measures should be taken.
出处 《青岛大学医学院学报》 CAS 2011年第2期126-128,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 高血压 E选择素 血管紧张素Ⅱ 降钙素基因相关肽 遗传 hypertension E-selectin angiotensin Ⅱ calcitonin gene-related peptide heredity
  • 相关文献

参考文献6

二级参考文献61

  • 1谭敦勇,姚兴海,赵东,汤健,唐朝枢.降钙素基因相关肽对内皮素释放的影响[J].中国病理生理杂志,1994,10(5):545-547. 被引量:49
  • 2陈海翎,华琦,刘荣坤,杨峥.E-选择素A561C基因多态性对高血压的影响[J].中华心血管病杂志,2005,33(7):603-607. 被引量:15
  • 3[1]Borghi C, Costa FV, Boschi S, et al. Factors associated with the development of stable hypertension in your borderline hypertensives[J]. J hypertens, 1996, Apr, 14(4):509-517
  • 4[2]孙宁铃,等主编.今日高血压.北京:中国医药科技出版社,1999:9
  • 5[3]Corol P,Soubrier F,Jeunermitre X. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension. Path Biol, 1997,45: 229-239
  • 6[4]Rotimi C, Cooper R, Ogumbiyi O, et al. Hypertension and serum angiotensin -nogen and molecular variants of the angiotension gene among nigerians. Circulation , 1997,95 : 2348-2350
  • 7[5]Soubrier F, Albence GF, Herbeth B, et al. Two putative Active Genters in Human Angiotensin I cloning [J]. ProcNatl Acad Sci USA, 1988,859(24): 9386-9390
  • 8[7]Taddei S, Virdis A, Mattei P, et al. Defective L-Arginine-Nitri Oxide pathway in offspring of essential hypertensive patients .Circulation, 1996; 94:1298
  • 9[8]Vanhoutte PM, Boulanger CM, Mombouli JV. Endothelium-derived relaxing factors and converting enzyme inhibition. AM J Cardiol, 1995; 76: 3
  • 10Ashida T, Kawano Y, Yoshimi H, et al. Effects of ouabain and verapamil on endothelin included contraction of mesenteric artery in young spontaneously hypertensive rats [ J ]. J Cardiovasc Pharmacol, 1991 ,17 ( suppl7 ) : 174 - 176.

共引文献326

同被引文献20

  • 1王久亮,佟长青.血浆中心钠素测定与蒙古族原发性高血压的关系[J].内蒙古医科大学学报,2013,35(S2):368-370. 被引量:1
  • 2KOLBEL T, ALHADAD A, ACOSTA S, et al. Thrombus embolization into IVC filters during catheter-directed throm- bolysis for proximal deep venous thrombosis[J]. Journal of Endovascular Therapy, 2008,15 :605-613.
  • 3VITTORIO P, ANTHONIE W, MARTIN H, et al. Inci- dence of chronic thromboembolic pulmonary hypertension after pulmonary embolisim[J]. New England Journal of Medicine, 2004,350 (22):2257-2264.
  • 4VERHAEGHE R, MALEUX G. Endovascular local thrombo- lytic therapy of iliofemoral and inferior caval vein thrombosis[J]. Seminars in Vascular Medicine,2001,1(1):123-128.
  • 5GRUNWALD M R, HOFMANN L V. Comparison of Uroki nase, Alteplase, and Reteplase for catheter-directed thrombol ysis of deep venous thrombosis[J]. Journal of Vascular Inter ventional Radiology, 2004,15 (4) : 347-352.
  • 6AGLE S C, MCNALLY M M, POWELL C S, et al. The as- sociation of periproeedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis[J]. An-nals of Vascular Surgery, 2010,24(5) :609-614.
  • 7HOPPE H, NUTTING C W, ROBERT SMOUSE H, et al. Gtinther Tulip filter retrievability multieenter study including CT follow-up: final report[J]. Journal of Vascular Radiology, 2006,17 (6) : 1017-1023.
  • 8下肢深静脉血栓形成介入治疗规范的专家共识[J].中华放射学杂志,2011,45(3):293-296. 被引量:112
  • 9中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616. 被引量:4549
  • 10王志忠.原发性高血压患者ET、CGRP、NO和NOS联合检测的临床意义[J].中国热带医学,2011,11(9):1149-1150. 被引量:4

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部